These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 7645915)

  • 21. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement.
    Eriksson BI; Wille-Jørgensen P; Kälebo P; Mouret P; Rosencher N; Bösch P; Baur M; Ekman S; Bach D; Lindbratt S; Close P
    N Engl J Med; 1997 Nov; 337(19):1329-35. PubMed ID: 9358126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.
    Arch Intern Med; 1991 Aug; 151(8):1621-4. PubMed ID: 1714709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
    Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
    Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Stephens JW; Gardiner GA; Ritter MA
    Clin Orthop Relat Res; 1995 Dec; (321):19-27. PubMed ID: 7497668
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group.
    Gazzaniga GM; Angelini G; Pastorino G; Santoro E; Lucchini M; Dal Prà ML
    Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enoxaparin Clinical Trial Group.
    Spiro TE; Johnson GJ; Christie MJ; Lyons RM; MacFarlane DE; Blasier RB; Tremaine MD
    Ann Intern Med; 1994 Jul; 121(2):81-9. PubMed ID: 8017740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin.
    Tapson VF; Hull RD
    Clin Chest Med; 1995 Jun; 16(2):281-94. PubMed ID: 7656540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hip fracture patients treated in a community hospital setting.
    Ennis RS
    J South Orthop Assoc; 2003; 12(1):10-7. PubMed ID: 12735619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged prophylaxis with unfractioned heparin is effective to reduce delayed deep vein thrombosis in total hip replacement.
    Manganelli D; Pazzagli M; Mazzantini D; Punzi G; Manca M; Vignali C; Palla A; Troiani R; Rossi G
    Respiration; 1998; 65(5):369-74. PubMed ID: 9782219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.
    Lynd LD; Goeree R; Crowther MA; O'Brien BJ
    Can J Clin Pharmacol; 2007; 14(2):e215-26. PubMed ID: 17652767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enoxaparin for the prevention of post surgical pulmonary embolism].
    Xia XY; Tan YL; Sun YW; Yan GD; Rong YX; Ren QH; Liu JY; Xu XZ; Shan GP; Jin L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Nov; 23(11):661-4. PubMed ID: 22093311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin.
    Planès A; Samama MM; Lensing AW; Büller HR; Barre J; Vochelle N; Beau B
    Thromb Haemost; 1999 Jan; 81(1):22-5. PubMed ID: 10348714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis.
    Chong BH; Brighton TA; Baker RI; Thurlow P; Lee CH;
    J Thromb Thrombolysis; 2005 Jun; 19(3):173-81. PubMed ID: 16082604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group.
    Br J Surg; 1997 Aug; 84(8):1099-103. PubMed ID: 9278651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
    Haas S; Flosbach CW
    Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].
    Weber U; Koppenhagen K; Mälzer H; Matthes M
    Langenbecks Arch Chir; 1991; 376(3):147-51. PubMed ID: 1651434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dalteparin: a low-molecular-weight heparin.
    Howard PA
    Ann Pharmacother; 1997 Feb; 31(2):192-203. PubMed ID: 9034422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11).
    Moreno Gonzalez E; Fontcuberta J; de la Llama F
    Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.